0001179110-20-011606.txt : 20201203 0001179110-20-011606.hdr.sgml : 20201203 20201203161023 ACCESSION NUMBER: 0001179110-20-011606 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201201 FILED AS OF DATE: 20201203 DATE AS OF CHANGE: 20201203 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hurley Ariel CENTRAL INDEX KEY: 0001769740 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37359 FILM NUMBER: 201367012 MAIL ADDRESS: STREET 1: C/O BLUEPRINT MEDICINES CORPORATION STREET 2: 45 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Blueprint Medicines Corp CENTRAL INDEX KEY: 0001597264 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 45 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-374-7580 MAIL ADDRESS: STREET 1: 45 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 edgar.xml FORM 4 - X0306 4 2020-12-01 0 0001597264 Blueprint Medicines Corp BPMC 0001769740 Hurley Ariel C/O BLUEPRINT MEDICINES CORPORATION 45 SIDNEY STREET CAMBRIDGE MA 02139 0 1 0 0 Principal Accounting Officer Common Stock 2020-12-01 4 S 0 138 109.08 D 9984 D Common Stock 2020-12-01 4 M 0 900 8.8 A 10884 D Common Stock 2020-12-01 4 S 0 900 110 D 9984 D Stock Option (Right to Buy) 8.8 2020-12-01 4 M 0 900 0 D 2025-02-10 Common Stock 900 2964 D Effected pursuant to a trading plan adopted on March 17, 2020 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Consists of 138 shares that were acquired under the Issuer's employee stock purchase plan on November 30, 2020. This option was granted on February 10, 2015 and is fully vested as of the date hereof. /s/ Christopher Frankenfield, Attorney-in-Fact 2020-12-03